Eric is a biotech entrepreneur focused on advancing genetic medicines to address unmet medical needs. He currently serves as the Chief Operating Officer at Oisín Biotechnologies, a company with which he has been involved since its inception. Additionally, Eric helped establish OncoSenX to combat solid tumors and Immusoft, the world's first B-Cell reprogramming company. Eric has a bachelor's degree in Economics & Political Science from Western Washington University.